Clinical Trial Update: Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia [Phase 1]

View source ↗

Summary

Phase 1 trial of eltrombopag for preventing chemotherapy-induced thrombocytopenia in soft tissue sarcoma and osteosarcoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Promacta (eltrombopag)

Snippet

Sponsor: Duke University | Conditions: Sarcoma, Soft Tissue, Osteosarcoma | Phase 1 | Status: TERMINATED